C.Q. Pharmaceutical Holding: Announcement of the results of the fifth short-term financing bond issuance of the holding subsidiary in 2024.
C.Q. Pharmaceutical Holding: Summary of the Acquisition Report.
C.Q. Pharmaceutical Holding: Announcement on Progress of Indirect Shareholder Signing the Agreement on Gratuitous Transfer and Intended Change of Actual Controller
C.Q. Pharmaceutical Holding: Voluntary Information Disclosure Notice on the Signing of the Strategic Cooperation Framework Agreement
C.Q. Pharmaceutical Holding: Lawyers of Beijing Jingtian Gongcheng Law Firm witness legal opinion on the 2023 Annual General Meeting of Shareholders of Heavy Pharmaceutical Holdings Co., Ltd.
C.Q. Pharmaceutical Holding: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
C.Q. Pharmaceutical Holding: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
C.Q. Pharmaceutical Holding: Announcement on the holding subsidiary obtaining a drug registration certificate
C.Q. Pharmaceutical Holding: Internal Control Self-Assessment Report
C.Q. Pharmaceutical Holding: 2024 Financial Budget Report
C.Q. Pharmaceutical Holding: 2023 Financial Results Report
C.Q. Pharmaceutical Holding: Report of the Board of Auditors on the performance of supervisory duties by accounting firms
C.Q. Pharmaceutical Holding: Announcement on preparation for depreciation
C.Q. Pharmaceutical Holding: Announcement on the successful establishment of the holding subsidiary “Chongqing Pharmaceutical Accounts Receivable Phase 1 Asset Support Special Plan”
C.Q. Pharmaceutical Holding: Special instructions on financial services such as deposits and loans involving transactions related to financial companies in 2023 of Heavy Pharmaceutical Holdings Co., Ltd.
C.Q. Pharmaceutical Holding: Notice of Annual General Meeting of Shareholders
Heavy Pharmaceutical Holdings: Announcement on the results of issuing the holding subsidiary's third instalment medium-term notes in 2024
Heavy Pharmaceutical Holdings: Announcement on the results of issuing the holding subsidiary's fourth ultra-short-term financing note in 2024
Heavy Pharmaceutical Holdings: Announcement on the issuance results of the holding subsidiary\'s third ultra-short-term financing note in 2024
Heavy Pharmaceutical Holdings: Lawyers from Beijing Jingtian Gongcheng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Heavy Pharmaceutical Holdings Co., Ltd. witnessed the legal opinion
No Data